NASDAQ: ANGNAngion Biomedica Corp Stock Ownership - Who owns Angion Biomedica?
Insider buying vs selling
Have Angion Biomedica Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Itzhak Goldberg | Director | 2022-07-01 | 32,082 | $1.12 | $35.93kSell |
| Jay Venkatesan | Director | 2022-05-25 | 11,313 | $1.25 | $14.11kBuy |
| Jay Venkatesan | President and Chief Executive Officer and Director | 2022-05-24 | 32,200 | $1.24 | $39.93kBuy |
| Allen Nissenson | Director | 2022-05-20 | 2,037 | $1.18 | $2.40kBuy |
| Jay Venkatesan | President and Chief Executive Officer and Director | 2022-05-20 | 50,000 | $1.23 | $61.50kBuy |
| Allen Nissenson | Director | 2022-05-19 | 7,346 | $1.16 | $8.52kBuy |
ANGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANGN insiders and whales buy or sell their stock.
ANGN Shareholders
What type of owners hold Angion Biomedica Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eisaabc LLC | 9.10% | 2,740,978 | $1.59M | Insider |
| Jay Venkatesan | 6.28% | 1,891,947 | $1.10M | Insider |
| Itzhak Goldberg | 5.61% | 1,687,986 | $979.03k | Insider |
| Bvf Inc | 3.56% | 1,071,297 | $621.35k | Institution |
| Nantahala Capital Management LLC | 3.43% | 1,033,145 | $599.22k | Institution |
| Victor F. Ganzi | 3.25% | 978,698 | $567.64k | Insider |
| Cm Management LLC | 2.43% | 732,178 | $424.66k | Institution |
| Vanguard Group Inc | 2.14% | 644,035 | $373.54k | Institution |
| Park West Asset Management LLC | 1.23% | 370,724 | $215.02k | Institution |
| Bridgeway Capital Management LLC | 0.58% | 175,000 | $101.50k | Institution |
ANGN vs Biotech Stocks
Angion Biomedica Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.